72.9 F
New York
Tuesday, July 7, 2020
Home Healthcare

Healthcare

Healthcare company and market news.

Just as the coronavirus makes its way around the world, the U.S. reported its first death from the virus. A man in his 50s from Seattle, Washington who had chronic health issues was the first casualty of the disease. Meanwhile, a cluster outbreak was also reported in...
As concerns mount about the coronavirus, a dozen or so biotech companies have ramped up their efforts to fight the disease. And, investors are taking note. Vir Biotechnology stock soared 111 percent over the past month. Novavax also surged 91 percent. Investors are betting that biotech will...
In what will be an all-stock transaction, CoImmune Inc. and Formula Pharmaceutical have agreed to merge their companies. The pharma-enterprises will bring together two oncologic biotech platforms based on immune system therapies. In particular, the combined company will focus on a Phase 1 trial...
The U.S. Food and Drug Administration (FDA) has announced the approval of Ubrelvy, to Allergan USA, Inc., to treat migraine headaches. Ubrelvy, or its generic name ubrogepant, is part of a class of drugs that are oral calcitonin gene-related peptide receptor antagonists. The FDA says ubrogepant is...
The Canadian pharmaceutical biotech company, Aurinia, saw shares skyrocket on Thursday. Shares nearly doubled in a 24-hour period following good news about its lupus drug, voclosporin.  Lupus is a chronic autoimmune disease where a person’s own immune system becomes overactive. The result is that...
Biotech stocks were up 8 percent in October. During the same month, the S&P 500 was up by nearly 2 percent. The iShares NASDAQ Biotechnology Index (IBB) is set for its best month since the beginning of the year. In January, the IBB gained 13.75 percent.
According to a survey by OptumIQ, 62 percent of health care leaders say their organizations have initiated artificial intelligence strategies in 2019. Compared to last year, this is an 88 percent increase. Of these, 90 percent believe they’ll receive a return on their investment earlier than initially...
One of the nation’s leading pharmaceutical companies has entered into an agreement that will strengthen its position in biopharmacy and as a leader in oncology. Pfizer and Array Biopharma have announced that they’ve entered into a definitive merger agreement, a contract that will allow Pfizer to acquire...
A new report from former Wall Street securities analyst Mary Meeker shows that the healthcare industry is becoming more digitized. The report, Internet Trends, illustrates that the healthcare ecosystem is focused on updating its systems and practices to deliver more personalized healthcare. Health wearables...
The American College of Cardiology (ACC) and the data analytical firm Veradigm have entered into a partnership. The collaboration is an effort to usher in the next generation of research on cardiology and diabetes. The partnership will help to create the biggest ambulatory chronic...